Clinical Trial Update: A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating AC chemotherapy followed by paclitaxel plus trastuzumab and/or lapatinib given before surgery in operable HER2-positive invasive breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (Adriamycin) (doxorubicin)
• Lapatinib (Lapatinib)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Invasive Breast Cancer | Phase 3 | Status: UNKNOWN